SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001724287-19-000002
Filing Date
2019-04-24
Accepted
2019-04-24 17:15:06
Documents
1
Effectiveness Date
2019-04-24
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11379
  Complete submission text file 0001724287-19-000002.txt   12471
Mailing Address 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL 35215
Business Address 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL 35215 251-401-1187
Bridge Therapeutics, Inc. (Filer) CIK: 0001724287 (see all company filings)

IRS No.: 473513057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-306250 | Film No.: 19764578